T cell immunoglobulin and mucin domain-containing 3 (Tim-3) is an inhibitory receptor that is expressed on exhausted T cells during infection with HIV-1 and hepatitis C virus. By contrast, Tim-3 expression and function are defective in multiple human autoimmune diseases. However, the molecular mechanisms modulating Tim-3 function are not well understood. Here we show that human leukocyte antigen B (HLA-B)-associated transcript 3 (Bat3) binds to, and represses the function of, Tim-3. Bat3 protects T helper type 1 (T H 1) cells from galectin-9-mediated cell death and promotes both proliferation and proinflammatory cytokine production. Bat3-deficient T cells have elevated expression of exhaustion-associated molecules such as Tim-3, Lag3, Prdm1 and Pbx3, and Bat3 knockdown in myelin-antigen-specific CD4 + T cells markedly inhibits the development of experimental autoimmune encephalomyelitis while promoting the expansion of a dysfunctional Tim-3 hi , interferon-g (IFN-g) lo CD4 + cell population. Furthermore, expression of Bat3 is reduced in exhausted Tim-3 + T cells from mouse tumors and HIV-1-infected individuals. These data indicate that Bat3 acts as an inhibitor of Tim-3-dependent exhaustion and cell death. Bat3 may thus represent a viable therapeutic target in autoimmune disorders, chronic infections and cancers. 
IFN-γ-secreting T H 1 CD4 + cells and cytotoxic T type 1 (T C 1) CD8 + cells have an essential role in protection against intracellular pathogens and viruses, and IFN-γ production from lymphocytes is a crucial component of tumor immunosurveillance 1 and resistance to chronic viral infections 2, 3 . T H 1 responses to self antigens are, however, thought to promote autoimmune disease in rodents and humans 3, 4 . Thus, IFN-γ-producing T cells induce human autoimmune diseases and protect against chronic viral infections and cancers.
Tim-3 (encoded by Havcr2) is an inhibitory receptor that is specifically expressed on terminally differentiated T H 1 and T C 1 cells 5 and can trigger cell death on interaction with its ligand, galectin-9 (ref. 6 ). Tim-3 is crucial for the induction of T cell tolerance in vivo 7, 8 , and defective Tim-3 expression and signaling have been observed in CD4 + T cells isolated from patients with multiple sclerosis 9,10 and colitis 11 . Furthermore, recent findings showed that Tim-3 has a crucial role in the development of T cell exhaustion in chronic viral infections such as HIV 12 , hepatitis C virus (HCV) 13 , lymphocytic choriomeningitis virus 14 and Friend virus infections 15 , as well as in tumorbearing individuals [16] [17] [18] . Notably, the amount of Tim-3 expression on HIV-1-specific T cells correlates with their sensitivity to regulatory T cell-mediated suppression 19 .
The galectin-9-Tim-3 axis is thus an important negative regulator of T H 1 and T C 1 cell function that could be exploited therapeutically.
Whereas boosting Tim-3 signals could dampen autoimmunity, repressing Tim-3 function could augment immune responses to viral infections and cancers. Developing such strategies requires greater insight into the molecular mechanisms of Tim-3-mediated T cell regulation. Here we identify Bat3 (encoded by Bag6) as a binding partner to the Tim-3 intracellular tail. Bat3 protects T H 1 cells from galectin-9-mediated cell death and promotes both proliferation and proinflammatory cytokine production. In contrast, knockdown of Bat3 in myelin-antigen-specific T H 1 cells ablates their function and pathogenicity and promotes T cell exhaustion in vivo. Further, Bat3 expression is specifically reduced in exhausted Tim-3 + CD4 + T cells isolated from mouse tumors and HIV-1-infected individuals. Bat3 thus represents a newly identified repressor of Tim-3 signaling that protects T H 1 responses from Tim-3-mediated inhibition.
RESULTS

Tim-3 binds to Bat3
To identify putative intracellular binding partners for Tim-3, we used a yeast two-hybrid approach to screen a mouse spleen complementary DNA library using the intracellular portion of Tim-3 as bait (Fig. 1a) . Eleven clones corresponded to Bat3, a proline-rich cytoplasmic protein that regulates mammalian cell proliferation and death 20, 21 .
To confirm the Bat3-Tim-3 interaction, we overexpressed tagged mouse Bat3 and Tim-3 constructs in HEK 293T cells (Fig. 1a) and found that Tim-3 coimmunoprecipitated with Bat3 (Fig. 1b) . Endogenous Tim-3 and Bat3 also coimmunoprecipitated in lymphocytes 22 ( Supplementary Fig. 1 ). Using the Tim-3 deletion constructs Tim-3 ∆252-281 and Tim-3 ∆271-281 (Fig. 1a) , we identified residues 252-270 of Tim-3 as being crucial for mediating binding to Bat3 (Fig. 1c) . To study a potential role for the Tim-3 ligand galectin-9 in regulating the binding of Bat3 to the Tim-3 tail, we expressed galectin-9 with Bat3 and Tim-3 in HEK 293T cells. Notably, expression of galectin-9 together with Bat3 and Tim-3 abolished the binding of Bat3 to Tim-3 ( Fig. 1d) . As galectin-9 can induce phosphorylation of the Tim-3 tail 23 , we tested whether the phosphorylation of residues Tyr256 and Tyr263 is required for the galectin-9-mediated release of Bat3 from Tim-3. A Tim3 complementary DNA in which we replaced these two crucial tyrosines with phenylalanine residues (Tim-3 2YF ; Fig. 1a ) could still bind Bat3. However, in contrast to wild-type Tim-3, galectin-9 could not disrupt the binding of Tim-3 2YF to Bat3 (Fig. 1d) . Taken together, our data show that Bat3 binds to residues 252-270 of Tim-3 and that galectin-9 disrupts this interaction by inducing the phosphorylation of two tyrosine residues (Tyr256 and Tyr263) in the Tim-3 tail.
Bat3 protects T H 1 cell responses from inhibition by Tim-3
Using an antisera generated against the N terminus of Bat3 (Supplementary Fig. 2 ), we found that Bat3 is primarily expressed in T H 1 cells (Fig. 2a) . We observed markedly lower expression of Bat3 in nonpolarized T H 0 cells as well as in polarized T H 17 ( Fig. 2a) and T H 2 ( Supplementary Fig. 3 ) cells. These data, taken together with our finding that galectin-9 abrogates the interaction of Tim-3 with Bat3 ( Fig. 1d) , suggest that Bat3 can regulate the Tim-3 signaling pathway. Notably, we found that Bat3 expression in T H 1 cells is lower in cells that do not express Tim-3 than in those that do ( Supplementary  Fig. 4) , suggesting that Tim-3 expression may be required for optimal Bat3 expression in activated T H 1 cells.
In mouse models, Bat3 can have contrasting, context-dependent effects on cell proliferation and survival 20, 21 . To determine whether Bat3 repressed or promoted Tim-3-mediated inhibition, we retrovirally overexpressed Bat3 (Supplementary Fig. 5 Fig. 2b) . Notably, mice that received Bat3-overexpressing 2D2 T H 1 cells developed earlier onset experimental autoimmune encephalomyelitis (EAE) that was of greater clinical severity compared to mice that received control 2D2 T H 1 cells (Supplementary Fig. 7 ). Thus, Bat3 overexpression promotes T H 1 cell responses.
To directly assess the effect of Bat3 on signaling through the galectin-9-Tim-3 axis, we assessed the ability of galectin-9 to induce the death of Bat3-overexpressing T H 1 cells. A lower percentage of Bat3-transduced T H 1 cells underwent cell death than did control vector-transduced T H 1 cells after galectin-9 treatment (Fig. 2d) , suggesting that Bat3 protects T H 1 cells from Tim-3-dependent inhibitory signals both in vitro and in vivo.
Loss of Bat3 reduces EAE severity
As Bat3 seemed to protect T H 1 cells from the inhibitory functions of Tim-3, loss of Bat3 in vivo could dampen autoimmunity by leaving the inhibitory functions of Tim-3 unopposed. We therefore tested the consequences of Bat3 ablation in mouse EAE, an autoimmune disease driven primarily by inflammatory CD4 + cells reactive against myelin antigens 25 that can be induced by T H 1 cells independently of T H 17 cells 26 .
Bat3 deficiency results in embryonic lethality in the C57BL/6J mouse strain 20, 21 . We therefore generated chimeric mice by transferring Bag6 +/− or Bag6 −/− fetal liver cells into Rag1 −/− mice. We immunized these chimeras with MOG and monitored them for the development of EAE. Bag6 −/− →Rag1 −/− mice developed disease of significantly lower severity compared to their Bag6 +/− →Rag1 −/− counterparts (P < 0.0001; Fig. 3a,b) , suggesting that Bat3 has an important role in promoting T cell-driven autoimmunity. Further, we observed a significantly lower frequency of IFN-γ-producing (P < 0.041), but not IL-17-or IL-2-producing, CD4 + T cells in the peripheral lymphoid tissues of Bag6 −/− →Rag1 −/− than of Bag6 +/− →Rag1 −/− MOGimmunized mice (Fig. 3c ).
Bat3-deficient T cells have an exhausted-like phenotype
To gain a better understanding of the consequences of the loss of function of Bat3 on the generation of effector T cell responses, we isolated CD4 + T cells from Bag6 +/− →Rag1 −/− and Bag6 −/− →Rag1 −/− mice in which lymphocytes had expanded homeostatically in a lymphopenic environment. We noted a markedly lower frequency of IFN-γ-and IL-2-producing T cells in the absence of Bat3 expression (Fig. 4a) . These Bat3-deficient CD4 + T cells also expressed higher amounts of intracellular IL-10 and surface Tim-3 (Fig. 4a) . This IFN-γ lo IL-2 lo IL-10 hi Tim-3 hi phenotype shares many of the characteristics of exhausted T cells [12] [13] [14] 16, 18, 27, 28 .
A number of groups, including ours, have identified Tim-3 as a functional marker of exhausted T cells [11] [12] [13] [14] [15] [16] [17] [18] . Further, T cells with an exhausted-like phenotype have been observed in Rasgrp1 −/− mice, which are T cell lymphopenic 29 . This raised the possibility that homeostatic expansion of Bag6 −/− T cells in Rag1 −/− mice might favor the generation of an exhaustion-like phenotype in these cells. In addition to their high Tim-3 expression, we found that Bat-3-deficient CD4 + T cells upregulated a number of exhaustion-associated markers, such as the transcription factors Prdm1 (ref. (Fig. 4b) . These data suggest that in the absence of Bat3, homeostatic expansion of CD4 + T cells in a lymphocyte-deficient environment can result in the development of an exhaustion-like T cell phenotype.
We next explored the potential mechanism(s) of Bat3 function in promoting T H 1 cell responses and in suppressing the generation of T cell exhaustion. We found that Tim-3 is incorporated into supramolecular activation clusters upon T cell activation (data not shown) and that Tim-3 signaling reduces T H 1 cell proliferation (Supplementary Fig. 8 ) and IFN-γ production 33 . We then found that there was higher expression of Tim-3 on Bat3-deficient CD3-ε lo CD4 + T cells as compared to Bat3-sufficient CD3-ε lo CD4 + cells. By contrast, we found no differences in Tim-3 expression between Bat3-deficient and Bat3-sufficient cells in the CD3-ε hi pool of CD4 + T cells (Fig. 4c) . These data suggest that loss of Bat3 function may favor the generation of a Tim-3 + CD3-ε lo CD4 + T cell population.
Tim-3 has recently been described as binding to TCR-associated Srcfamily kinases that are required for the transduction of TCR-dependent npg signals 33 . We found that Tim-3 could bind to the Src homology 3 (SH3)-domain-containing TCR-associated intracellular kinase Lck in a manner that was dependent on the presence of the Tim-3 intracellular tail (Fig. 4d) . We therefore asked whether Bat3, a proline-rich molecule, could interact with the SH3-domain-containing Lck in a Tim-3-dependent manner and thereby modulate the downstream effects of Tim-3. Bat3 and Lck physically interact when both molecules were expressed in HEK 293 cells (Supplementary Fig. 9 ). When Bat3 is retrovirally overexpressed in activated primary T H 1 cells, it could immunoprecipitate Lck. Notably, this interaction was abrogated when we treated the cells with an antibody to Tim-3 (Fig. 4e) . When phosphorylated at Tyr394, Lck becomes catalytically active and is able to phosphorylate downstream substrates that promote optimal T cell activation 34 . By contrast, phosphorylation of Lck at Tyr505 renders it catalytically inactive, and it has been proposed that T cell activation is at least partially regulated by the balance of active and inactive Lck within a cell 35 . Notably, Bat3 could pull down the catalytically active form of Lck (phosphorylated at Tyr394 (pTyr394)) in T H 1 cells (Fig. 4e) . Ligation of the Tim-3 receptor by a Tim-3-specific antibody inhibited this interaction. By contrast, Bat3 could not pull down catalytically inactive Lck in cells treated with the Tim-3-specific antibody or an isotype control. Notably, neither the total amounts of Lck nor the total amounts of phosphorylated Lck were perturbed by treatment with antibody to Tim-3 (Fig. 4e) . These data indicate that Bat3 can bind and recruit catalytically active Lck to the Tim-3 tail and that receptor ligation of Tim-3 triggers the release of the catalytically active form of Lck from Bat3.
We next asked whether loss of Bat3 could negatively regulate TCRmediated signaling by increasing the proportion of catalytically inactive Lck in T cells. Although there were low amounts of catalytically inactive Lck (pTyr505) in Bat3-sufficient T cells re-stimulated with antibodies to CD3 and CD28, a substantial amount of catalytically inactive Lck accumulated in Bat3-deficient T cells stimulated with the same antibodies (Fig. 4f ) . Thus, Tim-3, which is recruited to the supramolecular activation cluster during T cell activation, forms an intracellular molecular complex with Bat3 and the catalytically active form of Lck to promote T cell signaling, activation and expansion. However, loss of Bat3 results in the accumulation of the catalytically inactive form of Lck, which parallels the defective IL-2 production found in Bat3-deficient T cells.
Bat3 is crucial to induce T H 1 cell-driven autoimmunity
To study the consequences of loss of Bat3 function exclusively in T H 1 cell-driven autoimmunity, we devised a system for ablating Bat3 expression specifically in myelin-antigen-specific T cells. We generated an shRNA (Bat3KD1) that efficiently knocked down the expression of Bat3 in T cells (Supplementary Fig. 10 ). We then cultured CD4 + T cells under T H 1 polarizing conditions and retrovirally transduced them with either Bat3KD1 (Bat3KD1 2D2 T H 1 cells) or control retrovirus (control 2D2 T H 1 cells). Knockdown of Bat3 had no apparent affect on T cell viability (Supplementary Fig. 11 ). As the retrovirus constructs contained a bicistronic GFP reporter, we sorted GFP + cells and transferred them into Rag1 −/− recipient mice. All mice adoptively transferred with control 2D2 T H 1 cells developed EAE, whereas the severity and incidence of EAE was lower in mice adoptively transferred with Bat3KD1 2D2 T H 1 cells (Fig. 5a and Supplementary  Table 1) . Furthermore, the number of GFP + CD4 + cells infiltrating the central nervous system (CNS) of mice receiving Bat3KD1 2D2 T H 1 cells was fivefold lower as compared to mice receiving control 2D2 cells (Fig. 5b) . In addition, we observed significantly fewer inflammatory foci in the meninges (P < 0.0001) and CNS (P < 0.0011) of mice receiving Bat3KD1 2D2 T H 1 cells than those receiving control 2D2 T H 1 cells (Supplementary Table 1) . These findings show that Bat3 is crucial for the pathogenicity, survival or both of T H 1 cells and support a role for Bat3 in preserving T H 1 cell function in vivo. (Fig. 5c) . Notably, when we analyzed GFP + T cells (Supplementary Fig. 12 ) for cytokine production, we found that although Bat3KD1 2D2 T H 1 cells produced less IFN-γ than control 2D2 T H 1 cells, they produced substantially more IL-10 ( Fig. 5d) , a phenomenon that has been observed in exhausted T cells 14 .
To more closely link the interaction of Bat3 and Tim-3 to the maintenance of T H 1 cell responses, we transduced primary T H 1 cells with retrovirus gene expression constructs encoding the intracellular region of Tim-3 (Tim-3 IC ) or the intracellular region of Tim-3 lacking the Bat3-binding domain (Tim-3 IC∆Bat3BD ), which is located at amino acids 252-281 (Fig. 1a,c) . Expression of Tim-3 IC∆Bat3BD impaired IFN-γ production in T H 1 cells relative to control T H 1 cells transduced with empty retrovirus or Tim-3 IC -expressing retrovirus (Fig. 5e) . To formally show that the defects in T cell function observed after Bat3 knockdown were dependent on Tim-3, we knocked down Bat3 expression in both Havcr2 +/+ and Havcr2 −/− T H 1 cells using two different Bat3-specific shRNAs, Bat3KD1 and Bat3KD2 ( Supplementary  Fig. 10 ). Bat3 knockdown suppressed the proliferation of Havcr2 +/+ T H 1 cells (Fig. 5f ) but had little effect on the proliferative capacity of Havcr2 −/− T H 1 cells (Fig. 5f) . Knockdown of Bat3 also reduced the frequency of IFN-γ + IL-2 + CD4 + cells among Havcr2 +/+ , but not Havcr2 −/− , T H 1 cells (Fig. 5g) . These data indicate that the loss of T cell function (as assessed by proliferative capacity and the production of IFN-γ and IL-2) that accompanies the reduction of Bat3 expression is dependent on Tim-3.
Bat3 expression is reduced in Tim-3 + exhausted T cells Given the established role of Tim-3 in inducing and maintaining T cell exhaustion [12] [13] [14] [15] [16] [17] [18] , we asked whether Bat3 was differentially regulated in exhausted Tim-3 + T cells generated in vivo. We recently reported that Tim-3 expression characterizes a subpopulation of programmed cell death 1 (PD-1) + tumor infiltrating lymphocytes (TILs) that are exhausted and have impaired effector functions 16, 18 . Tim-3 + PD-1 + TILs isolated from both the 4T1 mammary adenocarcinoma (Fig. 6a) and CT26 colorectal carcinoma 16 models produce much lower amounts of IFN-γ and tumor necrosis factor α (TNF-α) than Tim-3 − PD-1 + TILs. Combined in vivo blockade of PD-1 signaling (using an antibody against programmed cell death ligand 1 (PD-L1)) and Tim-3 signaling increased IFN-γ production from TILs relative to either PD-1 or Tim-3 signal blockade alone (Fig. 6b) . These Tim-3 + PD-1 + TILs expressed 50% lower amounts of Bat3 mRNA relative to Tim-3 − PD-1 + cells (Fig. 6c) . To extend our findings to both chronic viral infections and human disease, we asked whether Bat3 was differentially expressed in Tim-3 + exhausted T cells isolated from untreated HIV-1-infected individuals 12 . We sorted Fig. 13 ). An analysis of a larger group of patients is required to ascertain whether there is any correlation between BAT3 expression in Tim-3 + T cells and viral load. Nevertheless, these data suggest that low BAT3 expression in T cells correlates with Tim-3 expression in vivo and with the development of functional exhaustion in both mouse and man. Although T cell exhaustion is detrimental in chronic viral infections and cancers, it may have evolved as a mechanism of peripheral tolerance to autoantigens and could thus be highly desirable in the context of autoimmune disorders such as multiple sclerosis. We therefore considered the possibility that downregulation of Bat3 expression could promote an exhaustion-like phenotype in T H 1 cells. We thus tested the effect of Bat3 downregulation on the development of in vivo effector T cell responses after adoptive transfer of 2D2 T H 1 cells into Rag1 −/− mice. The majority of the peripheral CD4 + T cells from mice receiving control 2D2 T H 1 cells were highly IFN-γ positive and did not express Tim-3. In contrast, T cells from 5 of 11 mice receiving Bat3KD1 2D2 T H 1 cells had a higher frequency of Tim-3 hi IFN-γ lo CD4 + cells in their peripheral lymphoid compartments (Fig. 6d) . The small number of IFN-γ hi CD4 + T cells that we isolated from these mice were all Tim-3 − (Fig. 6d) . Notably, the Tim-3 + IFN-γ lo CD4 + cells isolated from mice receiving Bat3KD1 2D2 T H 1 cells were also PD-1 − (Supplementary Fig. 14 ). Bat3-deficient T H 1 cells thus resemble the recently described Tim-3 + exhausted T lymphocyte population observed in chronic infections caused by HIV 12 or HCV 13 and in tumors 16, 18 in many ways, including low proliferation (Fig. 5f ), high Tim-3 expression coupled with low IFN-γ production (Figs. 4a and 6d) and high IL-10 production (Fig. 5d) . Thus, Bat3 may be a regulator of both T cell death and exhaustion in T H 1 cells.
DISCUSSION
Tim-3 is a key negative regulator of T cell function 5, 7, 8 , and dysregulated expression of Tim-3 has been implicated in many pathological conditions, including autoimmune disorders [9] [10] [11] , chronic viral infections [12] [13] [14] [15] 19 and malignancies [16] [17] [18] . However, in contrast to negative regulatory receptors such as cytotoxic T lymphocyte-associated protein 4 (CTLA-4) (reviewed in ref. 36 ) and PD-1 (refs. [37] [38] [39] , little is known about the intracellular molecules that interact with, and modulate the function of, Tim-3. Here we show that the molecular adaptor Bat3 binds to the intracellular tail of Tim-3 and protects T H 1 cells from Tim-3-mediated cell death or exhaustion. Bat3, the mammalian homolog of Drosophila Scythe, contains lengthy proline-rich tracts, making it an attractive molecular scaffold that can mediate multiple protein-protein interactions [40] [41] [42] [43] [44] . Interestingly, polymorphisms in the Bat3 locus have been linked to increased incidence of type I diabetes 45 , suggesting that regulation of Bat3 expression can affect the prevalence of human autoimmune disorders.
Our findings indicate that Bat3 can both promote IFN-γ production in vivo and render T H 1 cells resistant to galectin-9-mediated cell death. This suggests that the physical interaction of Bat3 with Tim-3 provides a means by which IFN-γ hi T H 1 cells can be protected from Tim-3-dependent negative regulation. Further, loss or decreased expression of Bat3 in CD4 + T cells reduces their encephalitogenic capacity and leads to the generation of a Tim-3 hi exhausted-like T cell population characteristic of that seen in HIV-1 and lymphocytic choriomeningitis virus infection, as well as in the context of mouse and human tumors [12] [13] [14] 16, 18 . Notably, we found low Bat3 expression in both mouse Tim-3 + TILs and in exhausted Tim-3 + CD4 + T cells isolated from untreated HIV-1-infected individuals. Promoting the interaction of Bat3 and Tim-3 in exhausted virus-or tumor-specific T cells could reverse their dysfunction. Further, our data point toward a new and possibly promising strategy in autoimmune therapy. By augmenting Tim-3 signaling in autoaggressive T cells, an inflammatory response that is characterized by tissue infiltration could potentially be shifted toward an exhausted response that is characterized by loss of T cell effector functions.
Taken together, our findings suggest that Bat3 promotes T H 1 effector responses by binding to and inhibiting Tim-3. The interaction of Tim-3 with its ligand galectin-9 abrogates the Bat3-Tim-3 binding activity, allowing Tim-3 to transduce inhibitory signals that limit T H 1 effector responses and potentially induce T cell exhaustion. Manipulation of the interaction between Bat3 and Tim-3 could be a promising molecular target for therapeutic intervention in autoimmune disease, cancer and chronic viral infections.
METHODS
Methods and any associated references are available in the online version of the paper. 
